Immune escape and exploitation strategies of cytomegaloviruses: Impact on and imitation of the major histocompatibility system

Cellular Microbiology

Volumn 6, Issue 8, 2004, Pages 707-717

  Mocarski Jr , Edward S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; VIRUS ANTIGEN;

ADAPTATION; ALLOTRANSPLANTATION; ANTIGEN PRESENTATION; BONE MARROW CELL; CELL FUNCTION; CELL INTERACTION; CELL LINEAGE; CYTOMEGALOVIRUS; FETUS DEVELOPMENT; GENETIC CODE; GENETIC VARIABILITY; HOST PATHOGEN INTERACTION; HOST RANGE; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENCE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOSURVEILLANCE; LIFESPAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MAMMAL; MOLECULAR MIMICRY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIMATE; PRIORITY JOURNAL; RECIPIENT; RODENT; SHORT SURVEY; T LYMPHOCYTE; VIRUS GENE; VIRUS NEUTRALIZATION; VIRUS PATHOGENESIS; VIRUS SURVIVAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EVOLUTION, MOLECULAR; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOLOGIC SURVEILLANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR MIMICRY; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IMMUNOLOGIC; VIRUS LATENCY;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; MAMMALIA; PRIMATES; RODENTIA;

EID: 4043117595     PISSN: 14625814     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2004.00425.x     Document Type: Short Survey

References (66)

1. Andrews, D.M., Scalzo, A.A., Yokoyama, W.M., Smyth, M.J., and Degli-Esposti, M.A. (2003) Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol 4: 175-181.
2. Arase, H., Mocarski, E.S., Campbell, A.E., Hill, A.B., and Lanier, L.L. (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
3. Arieh, S.V., Laham, N., Schechter, C., Yewdell, J.W., Coligan, J.E., and Ehrlich, R. (2003) A single viral protein HCMV US2 affects antigen presentation and intracellular iron homeostasis by degradation of classical HLA class I and HFE molecules. Blood 101: 2858-2864.
4. Basta, S., and Bennink, J.R. (2003) A survival game of hide and seek: cytomegaloviruses and MHC class I antigen presentation pathways. Viral Immunol 16: 231-242.
5. Beisser, P.S., Kloover, J.S., Grauls, G.E., Blok, M.J., Bruggeman, C.A., and Vink, C. (2000) The r144 major histocompatibility complex class I-like gene of rat cytomegalovirus is dispensable for both acute and long-term infection in the immunocompromised host. J Virol 74: 1045-1050.
6. Benz, C., and Hengel, H. (2000) MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons-an intricate balance. Virus Genes 21: 39-47.
7. Braud, V.M., Tomasec, P., and Wilkinson, G.W. (2002) Viral evasion of natural killer cells during human cytomegalovirus infection. Curr Top Microbiol Immunol 269: 117-129.
8. Bubic, I., Wagner, M., Krmpotic, A., Koszinowski, U., and Jonjic, S. (2004) The role of MCMV m157 gene product in NK cell-mediated control of MCMV infection in vivo. J Virol 78: in press
9. Carr, W.H., Little, A.M., Mocarski, E., and Parham, P. (2002) NK cell-mediated lysis of autologous HCMV-infected skin fibroblasts is highly variable among NK cell clones and polyclonal NK cell lines. Clin Immunol 105: 126-140.
10. Cosman, D., Fanger, N., and Borges, L. (1999) Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers. Immunol Rev 168: 177-185.
11. Cosman, D., Mullberg, J., Sutherland, C.L., Chin, W., Armitage, R., Fanslow, W., et al. (2001) ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14: 123-133.
12. Cretney, E., Degli-Esposti, M.A., Densley, E.H., Farrell, H.E., Davis-Poynter, N.J., and Smyth, M.J. (1999) m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. J Exp Med 190: 435-444.
13. Davison, A.J., Dargan, D.J., and Stow, N.D. (2002) Fundamental and accessory systems in herpesviruses. Antiviral Res 56: 1-11.
14. Davison, A.J., Dolan, A., Akter, P., Addison, C., Dargan, D.J., Alcendor, D.J., et al. (2003) The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J Gen Virol 84: 17-28.
15. Diefenbach, A., and Raulet, D.H. (2003) Innate immune recognition by stimulatory immunoreceptors. Curr Opin Immunol 15: 37-44.
16. Dunn, W., Chou, C., Li, H., Hai, R., Patterson, D., Stolc, V., et al. (2003a) Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci USA 100: 14223-14228.
17. Dunn, C., Chalupny, N.J., Sutherland, C.L., Dosch, S., Sivakumar, P.V., Johnson, D.C., and Cosman, D. (2003b) Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J Exp Med 197: 1427-1439.
18. Elkington, R., Walker, S., Crough, T., Menzies, M., Tellam, J., Bharadwaj, M., and Khanna, R. (2003) Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J Virol 77: 5226-5240.
19. Fahnestock, M.L., Johnson, J.L., Feldman, R.M, Neveu, J.M., Lane, W.S., and Bjorkman, P.J. (1995) The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 3: 583-590.
20. Farrell, H.E., Vally, H., Lynch, D.M., Fleming, P., Shellam, G.R., Scalzo, A.A., and Davis-Poynter, N.J. (1997) Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 386: 510-514.
21. Gold, M.C., Munks, M.W., Wagner, M., McMahon C.W., Kelly, A., Kavanaugh, D.G., et al. (2004) Murine cytomegalovirus interference with antigen presentation has little effect on the size or the 'effector memory' phenotype of the CD8 T cell response. J Immunol 172: 6944-6953.
22. Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M.S., Riddell, S.R., and Spies, T. (2001) Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2: 255-260.
23. Gutermann, A., Bubeck, A., Wagner, M., Reusch, U., Menard, C., and Koszinowski, U.H. (2002) Strategies for the identification and analysis of viral immune-evasive genes - cytomegalovirus as an example. Curr Top Microbiol Immunol 269: 1-22.
24. Hegde, N.R., Chevalier, M.S., and Johnson, D.C. (2003) Viral inhibition of MHC class II antigen presentation. Trends Immunol 24: 278-285.
25. Hegde, N.R., and Johnson, D.C. (2003) Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cells. J Virol 77: 9287-9294.
26. Heise, M.T., Connick, M., and Virgin, H.W.I. (1998) Murine cytomegalovirus inhibits interferon gamma-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes. J Exp Med 187: 1037-1046.
27. Hengel, H., Reusch, U., Gutermann, A., Ziegler, H., Jonjic, S., Lucin, P., and Koszinowski, U.H. (1999) Cytomegaloviral control of MHC class I function in the mouse. Immunol Rev 168: 167-176.
28. Huber, M.T., Tomazin, R., Wisner, T., Boname, J., and Johnson, D.C. (2002) Human cytomegalovirus US7, US8, US9, and US10 are cytoplasmic glycoproteins, not found at cell surfaces, and US9 does not mediate cell-to-cell spread. J Virol 76: 5748-5758.
29. Jenkins, C., Abendroth, A., and Slobedman, B. (2004) A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol 78: 1440-1447.
30. Jones, T.R., Hanson, L.K., Sun, L., Slater, J.S., Stenberg, R.M., and Campbell, A.E. (1995) Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J Virol 69: 4830-4841.
31. Kavanagh, D.G., Gold, M.C., Wagner, M., Koszinowski, U.H., and Hill, A.B. (2001a) The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. J Exp Med 194: 967-978.
32. Kavanagh, D.G., Koszinowski, U.H., and Hill, A.B. (2001b) The murine cytomegalovirus immune evasion protein m4/ gp34 forms biochemically distinct complexes with class I MHC at the cell surface and in a pre-Golgi compartment. J Immunol 167: 3894-3902.
33. Kern, F., Bunde, T., Faulhaber, N., Kiecker, F., Khatamzas, E., Rudawski, I.M., et al. (2002) Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J Infect Dis 185: 1709-1716.
34. Khan, S., Zimmermann, A., Basler, M., Groettrup, M., and Hengel, H. (2004) A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction. J Virol 78: 1831-1842.
35. Kondo, K., Xu, J., and Mocarski, E.S. (1996) Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci USA 93: 11137-11142.
36. Kostova, Z., and Wolf, D.H. (2003) For whom the bell tolls: protein quality control of the endoplasmic reticulum and the ubiquitin-proteasome connection. EMBO J 22: 2309-2317.
37. Krmpotic, A., Bubic, I., Polic, B., Lucin, P., and Jonjic, S. (2003) Pathogenesis of murine cytomegalovirus infection. Microbes Infect 5: 1263-1277.
38. Krmpotic, A., Busch, D.H., Bubic, I., Gebhardt, F., Hengel, H., Hasan, M., et al. (2002) MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat Immunol 3: 529-535.
39. Kubota, A., Kubota, S., Farrell, H.E., Davis-Poynter, N., and Takei, F. (1999) Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144. Cell Immunol 191: 145-151.
40. Leong, C.C., Chapman, T.L., Bjorkman, P.J., Formankova, D., Mocarski, E.S., Phillips, J.H., and Lanier, L.L. (1998) Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med 187: 1681-1687.
41. Lodoen, M., Ogasawara, K., Hamerman, J. A., Arase, H., Houchins, J. P., Mocarski, E. S. and Lanier, L. L. (2003) NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med 197: 1245-1253.
42. LoPiccolo, D.M., Gold, M.C., Kavanagh, D.G., Wagner, M., Koszinowski, U.H., and Hill, A.B. (2003) Effective inhibition of K(b)- and D(b)-restricted antigen presentation in primary macrophages by murine cytomegalovirus. J Virol 77: 301-308.
43. Miller, D.M., Cebulla, C.M., and Sedmak, D.D. (2002) Human cytomegalovirus inhibition of major histocompatibility complex transcription and interferon signal transduction. Curr Top Microbiol Immunol 269: 153-170.
44. Mocarski, E.S. (2002) Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol 10: 332-339.
45. Mocarski, E.S., Jr and Courcelle, C.T. (2001) Cytomegaloviruses and their replication. In Fields Virology. Knipe, D.M., Howley, P.M., Griffin, D.E., Lamb, R.A., Martin, M.A., Roizman, B., and Straus, S.E. (eds). Philadelphia: Lippincott Williams & Wilkins, pp. 2629-2673.
46. Momburg, F., and Hengel, H. (2002) Corking the bottleneck: the transporter associated with antigen processing as a target for immune subversion by viruses. Curr Top Microbiol Immunol 269: 57-74.
47. Mutimer, H.P., Akatsuka, Y., Manley, T., Chuang, E.L., Boeckh, M., Harrington, R., et al. (2002) Association between immune recovery uveitis and a diverse intraocular cytomegalovirus-specific cytotoxic T cell response. J Infect Dis 186: 701-705.
48. Odeberg, J., Browne, H., Metkar, S., Froelich, C.J., Branden, L., Cosman, D., and Soderberg-Naucler, C. (2003) The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins. J Virol 77: 4539-4545.
49. Park, B., Kim, Y., Shin, J., Lee, S., Cho, K., Fruh, K., and Ahn, K. (2004) Human cytomegalovirus inhibits tapasindependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity 20: 71-85.
50. Presti, R.M., Popkin, D.L., Connick, M., Paetzold, S., and Virgin, H.W. (2001) Novel cell type-specific antiviral mechanism of interferon gamma action in macrophages. J Exp Med 193: 483-496.
51. Redpath, S., Angulo, A., Gascoigne, N.R., and Ghazal, P. (1999) Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. J Immunol 162: 6701-6707.
52. Reyburn, H.T., Mandelboim, O., Vales-Gomez, M., Davis, D.M., Pazmany, L., and Strominger, J.L (1997) The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386: 514-517.
53. Scalzo, A.A. (2002) Successful control of viruses by NK cells - a balance of opposing forces? Trends Microbiol 10: 470-474.
54. Shiroishi, M., Tsumoto, K., Amano, K., Shirakihara, Y., Colonna, M., Braud, V.M., et al. (2003) Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci USA 100: 8856-8861.
55. Slobedman, B., Mocarski, E.S., Arvin, A.M., Mellins, E.D., and Abendroth, A. (2002) Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. Blood 100: 2867-2873.
56. Smith, H.R., Heusel, J.W., Mehta, I.K., Kim, S., Dorner, B.G., Naidenko, O.V., et al. (2002) Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 99: 8826-8831.
57. Spencer, J.V., Lockridge, K.M., Barry, P.A., Lin, G., Tsang, M., Penfold, M.E., and Schall, T.J. (2002) Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol 76: 1285-1292.
58. Sutherland, C.L., Chalupny, N.J., Schooley, K., VandenBos, T., Kubin, M., and Cosman, D. (2002) UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. J Immunol 168: 671-679.
59. Vales-Gomez, M., Browne, H., and Reyburn, H.T. (2003) Expression of the UL16 glycoprotein of human cytomegalovirus protects the virus-infected cell from attack by natural killer cells. BMC Immunol 4: 4.
60. Wagner, M., Gutermann, A., Podlech, J., Reddehase, M.J., and Koszinowski, U.H. (2002) Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J Exp Med 196: 805-816.
61. van der Wal, F.J., Kikkert, M., and Wiertz, E. (2002) The HCMV gene products US2 and US11 target MHC class I molecules for degradation in the cytosol. Curr Top Microbiol Immunol 269: 37-55.
62. Wang, E.C., McSharry, B., Retiere, C., Tomasec, P., Williams, S., Borysiewicz, L.K., et al. (2002) UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc Natl Acad Sci USA 99: 7570-7575.
63. Welte, S.A., Sinzger, C., Lutz, S.Z., Singh-Jasuja, H., Sampaio, K.L., Eknigk, U., et al. (2003) Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur J Immunol 33: 194-203.
64. Willcox, B.E., Thomas, L.M., and Bjorkman, P.J. (2003) Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat Immunol 3: 3.
65. Wu, J., Chalupny, N.J., Manley, T.J., Riddell, S.R., Cosman, D., and Spies, T. (2003) Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein. J Immunol 170: 4196-4200.
66. Yewdell, J.W., and Hill, A.B. (2002) Viral interference with antigen presentation. Nat Immunol 3: 1019-1025.